Annabel Nixon

1.9k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Annabel Nixon is a scholar working on Pediatrics, Perinatology and Child Health, Surgery and Nephrology. According to data from OpenAlex, Annabel Nixon has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 6 papers in Surgery and 6 papers in Nephrology. Recurrent topics in Annabel Nixon's work include Parathyroid Disorders and Treatments (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Epilepsy research and treatment (5 papers). Annabel Nixon is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Epilepsy research and treatment (5 papers). Annabel Nixon collaborates with scholars based in United Kingdom, United States and Italy. Annabel Nixon's co-authors include Cicely Kerr, D Wild, Katy Gallop, L Verdian, David Staskin, LuAnn Sabounjian, Shoshana Colman, Bobby W. Sandage, Ute Schwiderski and Norman R. Zinner and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Critical Care Medicine.

In The Last Decade

Annabel Nixon

32 papers receiving 1.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research

2010 364 citations Cicely Kerr, Annabel Nixon et al. Expert Review of Pharmacoeconomics & Outcomes Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Annabel Nixon United Kingdom	14	279	246	191	173	163	35	1.1k
Andreas M. Pleil United States	20	272 1.0×	86 0.3×	332 1.7×	308 1.8×	217 1.3×	60	2.1k
Petra Baji Hungary	25	197 0.7×	63 0.3×	230 1.2×	234 1.4×	152 0.9×	114	1.9k
Paul Swinburn United Kingdom	13	168 0.6×	157 0.6×	209 1.1×	77 0.4×	24 0.1×	30	1.6k
M.K.A. Basra United Kingdom	17	160 0.6×	103 0.4×	194 1.0×	91 0.5×	38 0.2×	22	1.9k
Lars Henningsohn Sweden	23	306 1.1×	187 0.8×	280 1.5×	175 1.0×	467 2.9×	58	2.3k
Isabel Cristina Gonçalves Leite Brazil	25	99 0.4×	134 0.5×	165 0.9×	130 0.8×	22 0.1×	216	2.0k
Seán Kennedy Australia	22	51 0.2×	92 0.4×	245 1.3×	509 2.9×	148 0.9×	102	1.7k
Katrina Wilcox Hagberg United States	19	108 0.4×	173 0.7×	134 0.7×	37 0.2×	35 0.2×	48	1.1k
F. Guillemin France	18	520 1.9×	72 0.3×	76 0.4×	99 0.6×	26 0.2×	50	1.2k
R Berzon United States	14	95 0.3×	281 1.1×	200 1.0×	233 1.3×	31 0.2×	23	1.7k

Countries citing papers authored by Annabel Nixon

Since Specialization

Citations

This map shows the geographic impact of Annabel Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annabel Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annabel Nixon more than expected).

Fields of papers citing papers by Annabel Nixon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annabel Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annabel Nixon. The network helps show where Annabel Nixon may publish in the future.

Co-authorship network of co-authors of Annabel Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Annabel Nixon. A scholar is included among the top collaborators of Annabel Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annabel Nixon. Annabel Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lachmann, Robin, Elaine Murphy, Gavin Clunie, et al.. (2025). Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphataemia (XLH) in the UK. Calcified Tissue International. 116(1). 122–122.

Linglart, Agnès, Iva Gueorguieva, Jérôme Harambat, et al.. (2025). Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry. JBMR Plus. 9(10). ziaf142–ziaf142.

Guttman‐Yassky, Emma, Ken Igawa, Kenji Kabashima, et al.. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. Dermatology and Therapy. 14(12). 3351–3366.

Lucas, Eleanor, et al.. (2024). Systematic literature review of the humanistic and economic burden of focal epilepsy and primary generalized tonic–clonic seizures in adults. Epilepsia Open. 9(6). 2055–2086. 1 indexed citations

Mushtaq, Talat, Sanjay Gupta, Angela Williams, et al.. (2024). Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH). Bone Reports. 24. 101819–101819. 1 indexed citations

Ortiz‐Romero, Pablo L., Y. H. Kim, Kevin Molloy, et al.. (2024). Health‐related quality of life in cutaneous T‐cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome. Journal of the European Academy of Dermatology and Venereology. 39(4). 833–845. 1 indexed citations

Kamenický, Peter, Karine Briot, Maria Luisa Brandi, et al.. (2023). Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open. 9(1). e002676–e002676. 20 indexed citations

Beur, Suzanne M. Jan de, Annabel Nixon, Christina Theodore‐Oklota, et al.. (2023). Burosumab Improves Patient-Reported Outcomes in Adults With Tumor-Induced Osteomalacia: Mixed-Methods Analysis. Journal of Bone and Mineral Research. 38(11). 1654–1664. 10 indexed citations

Nixon, Annabel, et al.. (2021). A qualitative investigation into the impact of hemophagocytic lymphohistiocytosis on children and their caregivers. Orphanet Journal of Rare Diseases. 16(1). 205–205. 5 indexed citations

10.

Nixon, Annabel, Angela Williams, & Christina Theodore‐Oklota. (2020). PRO80 PSYCHOMETRIC VALIDATION OF THE BRIEF FATIGUE INVENTORY (BFI) IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH). Value in Health. 23. S343–S343. 3 indexed citations

11.

Gallop, Katy, Cicely Kerr, Annabel Nixon, et al.. (2014). A Qualitative Investigation of Patients’ and Caregivers’ Experiences of Severe Sepsis*. Critical Care Medicine. 43(2). 296–307. 52 indexed citations

12.

Naegeli, April N., Annabel Nixon, Russel Burge, Deborah T. Gold, & Stuart L. Silverman. (2013). Development of the osteoporosis assessment questionnaire—physical function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function. Osteoporosis International. 25(2). 579–588. 6 indexed citations

13.

Gallop, Katy, et al.. (2012). Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective. Lupus. 21(9). 934–943. 52 indexed citations

14.

Kerr, Cicely, et al.. (2011). PMS66 Conceptual Model of the Impact of Hip Fracture on Patients' Lives. Value in Health. 14(7). A314–A314. 1 indexed citations

15.

Lloyd, Andrew, Paul Hodgkins, Rahul Sasané, et al.. (2011). Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations. Patient. 4(4). 247–257. 16 indexed citations

16.

Kerr, Cicely, Annabel Nixon, & D Wild. (2010). Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Review of Pharmacoeconomics & Outcomes Research. 10(3). 269–281. 364 indexed citations breakdown →

17.

Gallop, Katy, D Wild, L Verdian, et al.. (2009). Lennox-Gastaut Syndrome (LGS): Development of conceptual models of health-related quality of life (HRQL) for caregivers and children. Seizure. 19(1). 23–30. 47 indexed citations

18.

Gallop, Katy, D Wild, Annabel Nixon, L Verdian, & Joyce A. Cramer. (2009). Impact of Lennox-Gastaut Syndrome (LGS) on health-related quality of life (HRQL) of patients and caregivers: Literature review. Seizure. 18(8). 554–558. 53 indexed citations

19.

Nixon, Annabel & D Wild. (2008). PMC34 METHODOLOGIES FOR ASSESSING AND DEMONSTRATING DATA SATURATION IN QUALITATIVE INQUIRY SUPPORTING PATIENT-REPORTED OUTCOMES RESEARCH. Value in Health. 11(6). A569–A569. 3 indexed citations

20.

Goldwater, Paul N., et al.. (1989). Impact of a Recapping Device on Venepuncture-Related Needlestick Injury. Infection Control and Hospital Epidemiology. 10(1). 21–25. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact